Patents by Inventor Suanne Nakajima

Suanne Nakajima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tri-peptide hepatitis C serine protease inhibitors
    Publication number: 20050261200
    Abstract: The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: which inhibit serine protease activity, particularly the activity of hepatitis c virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis c virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
    Type: Application
    Filed: May 19, 2004
    Publication date: November 24, 2005
    Inventors: Zhenwei Miao, Ying Sun, Suanne Nakajima, Datong Tang, Zhe Wang, Yat Or
  • Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
    Patent number: 6951872
    Abstract: The present application describes monocyclic or bicyclic carbocycles and heterocycles and derivatives thereof of Formula I: or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.
    Type: Grant
    Filed: December 8, 2003
    Date of Patent: October 4, 2005
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Irina C. Jacobson, Ruth R. Wexler, Suanne Nakajima, Mimi L. Quan, Shuaige Wang, Joanne M. Smallheer, Jennifer Qiao
  • Macrocyclic hepatitis C serine protease inhibitors
    Publication number: 20050153877
    Abstract: The present invention relates to compounds of Formula I, II or Ill, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: wherein W is a substituted or unsubstituted heterocyclic ring system. The compounds inhibit serine protease activity, particularly the activity of hepatitis c virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis c virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
    Type: Application
    Filed: February 6, 2004
    Publication date: July 14, 2005
    Inventors: Zhenwei Miao, Ying Sun, Suanne Nakajima, Datong Tang, Frank Wu, Guoyou Xu, Yat Or, Zhe Wang
  • Aza-peptide macrocyclic hepatitis C serine protease inhibitors
    Publication number: 20050065073
    Abstract: The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
    Type: Application
    Filed: July 3, 2003
    Publication date: March 24, 2005
    Inventors: Frank Wu, Suanne Nakajima, Zhi-Hui Lu, Ying Sun, Zhenwei Miao, Yat Or, Zhe Wang
  • Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
    Publication number: 20040266668
    Abstract: The present invention relates to compounds of Formula I or II, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: 1
    Type: Application
    Filed: April 16, 2004
    Publication date: December 30, 2004
    Inventors: Suanne Nakajima, Miao Zhenwei, Ying Sun, Datong Tang, Guoyou Xu, Brian Porter, Yat Sun Or, Zhe Wang
  • Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
    Publication number: 20040180815
    Abstract: The present invention relates to compounds of Formula I or II, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: 1
    Type: Application
    Filed: March 7, 2003
    Publication date: September 16, 2004
    Inventors: Suanne Nakajima, Datong Tang, Frank Wu, Zhenwei Miao, Ying Sun, Yat Sun Or, Zhe Wang
  • Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
    Publication number: 20040132718
    Abstract: The present application describes monocyclic or bicyclic carbocycles and heterocycles and derivatives thereof of Formula I: 1
    Type: Application
    Filed: December 8, 2003
    Publication date: July 8, 2004
    Inventors: Irina C. Jacobson, Ruth R. Wexler, Suanne Nakajima, Mimi L. Quan, Shuaige Wang, Joanne M. Smallheer, Jennifer X. Qiao
  • Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
    Publication number: 20020183324
    Abstract: The present application describes monocyclic or bicyclic carbocycles and heterocycles and derivatives thereof of Formula I: 1
    Type: Application
    Filed: October 29, 2001
    Publication date: December 5, 2002
    Inventors: Irina C. Jacobson, Ruth R. Wexler, Suanne Nakajima, Mimi L. Quan, Shuaige Wang, Joanne M. Smallheer, Jennifer Qiao